Approval · Notice of Compliance 19090 · 2017
AZARGA: Notice of Compliance 19090
Issued March 23, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19090
- Date
- March 23, 2017
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification N umber
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZARGA | 02331624 | Marketed |
Medicinal ingredients
- TIMOLOL MALEATE 0.5 PER
- BRINZOLAMIDE 1 PER